Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vergis

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Toxicology and Applied Pharmacology|September 7, 2024
Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ consortium longer duration nonclinical to clinical translational databaseThomas M Monticello, David M Potter, Qihong Huang, et al.
Infection and Immunity|May 18, 2011
Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and miceMelissa K Wilson, James M Vergis, Farhang Alem, et al.
Clinical and Translational Science|June 2, 2026
Real-World Clinical Datasets in Practice: Applications for Learners, Clinician-Educators, and Health Services TeamsJacob F Wood, Jacob J Tan, Hunter M Eby, et al.
International Journal of Molecular Sciences|August 14, 2025
Identification of Drug Repurposing Candidates for Coxsackievirus B3 Infection in iPSC-Derived Brain-like Endothelial CellsJacob F Wood, John M Vergis, Ali S Imami, et al.
Brain, Behavior, & Immunity - Health|July 14, 2025
Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's diseaseBenjamin Siciliano, Nicholas D Henkel, William G Ryan V, et al.
Nature Reviews. Drug Discovery|May 21, 2024
The state of the art in secondary pharmacology and its impact on the safety of new medicinesRichard J Brennan, Stephen Jenkinson, Andrew Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion geneMamata Singh, Justin M Leasure, Christopher Chronowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2024
SKA2 enhances stress-related glucocorticoid receptor signaling through FKBP4-FKBP5 interactions in neuronsJakob Hartmann, Claudia Klengel, Larissa J Dillmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2024
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working GroupHelen E Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical DevelopmentRucha S Sane, Pallabi Mitra, Yurong Lai, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Toxicology and Applied Pharmacology|September 7, 2024
Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ consortium longer duration nonclinical to clinical translational databaseThomas M Monticello, David M Potter, Qihong Huang, et al.
Infection and Immunity|May 18, 2011
Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and miceMelissa K Wilson, James M Vergis, Farhang Alem, et al.
Clinical and Translational Science|June 2, 2026
Real-World Clinical Datasets in Practice: Applications for Learners, Clinician-Educators, and Health Services TeamsJacob F Wood, Jacob J Tan, Hunter M Eby, et al.
International Journal of Molecular Sciences|August 14, 2025
Identification of Drug Repurposing Candidates for Coxsackievirus B3 Infection in iPSC-Derived Brain-like Endothelial CellsJacob F Wood, John M Vergis, Ali S Imami, et al.
Brain, Behavior, & Immunity - Health|July 14, 2025
Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's diseaseBenjamin Siciliano, Nicholas D Henkel, William G Ryan V, et al.
Nature Reviews. Drug Discovery|May 21, 2024
The state of the art in secondary pharmacology and its impact on the safety of new medicinesRichard J Brennan, Stephen Jenkinson, Andrew Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion geneMamata Singh, Justin M Leasure, Christopher Chronowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2024
SKA2 enhances stress-related glucocorticoid receptor signaling through FKBP4-FKBP5 interactions in neuronsJakob Hartmann, Claudia Klengel, Larissa J Dillmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2024
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working GroupHelen E Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical DevelopmentRucha S Sane, Pallabi Mitra, Yurong Lai, et al.
Pageof 2